Krebs Biochemicals & Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 5.49 | 6.44 | 11.72 |
| Operating Expense | 7.57 | 11.51 | 16.18 |
| Net Profit | -5.32 | -8.27 | -7.74 |
| Net Profit Margin | -96.90 | -128.42 | -66.04 |
| Earning Per Share | -2.47 | -3.83 | -3.59 |
| EBIDTA | -2.07 | -5.07 | -4.46 |
| Effective Tax Rate | TBA | -0.39 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 5.49 |
| Operating Expense | 7.57 |
| Net Profit | -5.32 |
| Net Profit Margin | -96.90 |
| Earning Per Share | -2.47 |
| EBIDTA | -2.07 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 43.31 | 50.42 | 52.13 |
| Operating Expenses Annual | 58.34 | 59.15 | 67.91 |
| Operating Profit Annual | -14.32 | -8.27 | -15.16 |
| Interest Annual | 5.91 | 4.69 | 2.97 |
| Depreciation | 6.69 | 6.77 | 6.56 |
| Net Profit Annual | -26.94 | -19.73 | -24.69 |
| Tax Annual | 0.02 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 43.31 |
| Operating Expenses Annual | 58.34 |
| Operating Profit Annual | -14.32 |
| Interest Annual | 5.91 |
| Depreciation | 6.69 |
| Net Profit Annual | -26.94 |
| Tax Annual | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.14 | 0.09 | 0.10 |
| Cash Flow from Operations | -7.89 | 2.36 | -24.71 |
| Cash Flow from Investing | -4.97 | -7.82 | -12.65 |
| Cash Flow from Financing | 12.86 | 5.50 | 37.34 |
| Cash Flow at the End | 0.14 | 0.14 | 0.09 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.14 |
| Cash Flow from Operations | -7.89 |
| Cash Flow from Investing | -4.97 |
| Cash Flow from Financing | 12.86 |
| Cash Flow at the End | 0.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -33.06 | -16.40 | -29.08 |
| PBIT Margin (%) | -48.51 | -29.83 | -41.67 |
| PBT Margin (%) | -40.31 | -23.46 | -27.65 |
| Net PROFIT Margin (%) | -62.20 | -39.13 | -47.36 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -22.39 | -14.87 | -18.94 |
| Total Debt / Equity (X) | TBA | 2.83 | 0.78 |
| Asset Turnover Ratio (%) | 0.36 | 0.38 | 0.40 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -33.06 |
| PBIT Margin (%) | -48.51 |
| PBT Margin (%) | -40.31 |
| Net PROFIT Margin (%) | -62.20 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -22.39 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 147.55 | 151.80 | 149.16 |
| Total Current Assets Annual | 10.26 | 17.44 | 16.06 |
| Non Current Assets Annual | 158.78 | 160.73 | 158.92 |
| Total Shareholders Funds Annual | -146.24 | -119.22 | -99.46 |
| Total Assets Annual | 169.04 | 178.17 | 174.98 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 147.55 |
| Total Current Assets Annual | 10.26 |
| Non Current Assets Annual | 158.78 |
| Total Shareholders Funds Annual | -146.24 |
| Total Assets Annual | 169.04 |
No Data Availabe
